{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,19]],"date-time":"2026-05-19T04:11:20Z","timestamp":1779163880808,"version":"3.51.4"},"reference-count":30,"publisher":"Springer Science and Business Media LLC","issue":"10","license":[{"start":{"date-parts":[[2024,6,20]],"date-time":"2024-06-20T00:00:00Z","timestamp":1718841600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2024,6,20]],"date-time":"2024-06-20T00:00:00Z","timestamp":1718841600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"DOI":"10.13039\/100009619","name":"the Japan Agency for Medical Research and Development","doi-asserted-by":"crossref","award":["18dm0307003h0001"],"award-info":[{"award-number":["18dm0307003h0001"]}],"id":[{"id":"10.13039\/100009619","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Ann Nucl Med"],"published-print":{"date-parts":[[2024,10]]},"DOI":"10.1007\/s12149-024-01955-z","type":"journal-article","created":{"date-parts":[[2024,6,20]],"date-time":"2024-06-20T16:02:02Z","timestamp":1718899322000},"page":"835-846","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":4,"title":["Differential centiloid scale normalization techniques: comparison between hybrid PET\/MRI and independently acquired MRI"],"prefix":"10.1007","volume":"38","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-0265-5636","authenticated-orcid":false,"given":"Ryo","family":"Yamakuni","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Takenobu","family":"Murakami","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Naoyuki","family":"Ukon","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Takeyasu","family":"Kakamu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Wataru","family":"Toda","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kasumi","family":"Hattori","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hirofumi","family":"Sekino","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shiro","family":"Ishii","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kenji","family":"Fukushima","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hiroshi","family":"Matsuda","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yoshikazu","family":"Ugawa","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Noritaka","family":"Wakasugi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mitsunari","family":"Abe","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hiroshi","family":"Ito","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2024,6,20]]},"reference":[{"issue":"Suppl 1","key":"1955_CR1","doi-asserted-by":"publisher","first-page":"S3","DOI":"10.1017\/cjn.2016.18","volume":"43","author":"KM Fiest","year":"2016","unstructured":"Fiest KM, Jett\u00e9 N, Roberts JI, Maxwell CJ, Smith EE, Black SE, et al. The prevalence and incidence of dementia: a systematic review and meta-analysis. Can J Neurol Sci. 2016;43(Suppl 1):S3-50.","journal-title":"Can J Neurol Sci"},{"key":"1955_CR2","doi-asserted-by":"publisher","first-page":"241","DOI":"10.1136\/jnnp.2009.182477","volume":"9","author":"MI Kester","year":"2009","unstructured":"Kester MI, Scheltens P. Dementia: the bare essentials. Pract Neurol. 2009;9:241\u201351.","journal-title":"Pract Neurol"},{"key":"1955_CR3","doi-asserted-by":"publisher","first-page":"120","DOI":"10.1111\/j.1479-8301.2012.00415.x","volume":"12","author":"C Ikejima","year":"2012","unstructured":"Ikejima C, Hisanaga A, Meguro K, Yamada T, Ouma S, Kawamuro Y, et al. Multicentre population-based dementia prevalence survey in Japan: a preliminary report. Psychogeriatrics. 2012;12:120\u20133.","journal-title":"Psychogeriatrics"},{"key":"1955_CR4","doi-asserted-by":"publisher","first-page":"383","DOI":"10.1016\/0165-6147(91)90609-V","volume":"12","author":"J Hardy","year":"1991","unstructured":"Hardy J, Allsop D. Amyloid deposition as the central event in the aetiology of Alzheimer\u2019s disease. Trends Pharmacol Sci. 1991;12:383\u20138.","journal-title":"Trends Pharmacol Sci"},{"key":"1955_CR5","doi-asserted-by":"publisher","first-page":"101","DOI":"10.1385\/JMN:17:2:101","volume":"17","author":"JC Morris","year":"2001","unstructured":"Morris JC, Price JL. Pathologic correlates of nondemented aging, mild cognitive impairment, and early-stage Alzheimer\u2019s disease. J Mol Neurosci. 2001;17:101\u201318.","journal-title":"J Mol Neurosci"},{"key":"1955_CR6","doi-asserted-by":"publisher","first-page":"1630","DOI":"10.1093\/brain\/awn016","volume":"131","author":"MD Ikonomovic","year":"2008","unstructured":"Ikonomovic MD, Klunk WE, Abrahamson EE, Mathis CA, Price JC, Tsopelas ND, et al. Post-mortem correlates of in vivo PiB-PET amyloid imaging in a typical case of Alzheimer\u2019s disease. Brain. 2008;131:1630\u201345.","journal-title":"Brain"},{"key":"1955_CR7","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1016\/j.neurobiolaging.2023.03.007","volume":"127","author":"K Kasuga","year":"2023","unstructured":"Kasuga K, Tsukie T, Kikuchi M, Tokutake T, Washiyama K, Shimizu S, et al. The clinical application of optimized AT(N) classification in Alzheimer\u2019s clinical syndrome (ACS) and non-ACS conditions. Neurobiol Aging. 2023;127:23\u201332.","journal-title":"Neurobiol Aging"},{"key":"1955_CR8","doi-asserted-by":"publisher","first-page":"170","DOI":"10.1016\/j.clinph.2023.12.131","volume":"158","author":"T Murakami","year":"2024","unstructured":"Murakami T, Abe M, Tiksnadi A, Nemoto A, Futamura M, Yamakuni R, et al. Abnormal motor cortical plasticity as a useful neurophysiological biomarker for Alzheimer\u2019s disease pathology. Clin Neurophysiol. 2024;158:170\u20139.","journal-title":"Clin Neurophysiol"},{"key":"1955_CR9","doi-asserted-by":"publisher","first-page":"249","DOI":"10.1038\/nature25456","volume":"554","author":"A Nakamura","year":"2018","unstructured":"Nakamura A, Kaneko N, Villemagne VL, Kato T, Doecke J, Dor\u00e9 V, et al. High performance plasma amyloid-\u03b2 biomarkers for Alzheimer\u2019s disease. Nature. 2018;554:249\u201354.","journal-title":"Nature"},{"key":"1955_CR10","doi-asserted-by":"publisher","first-page":"154","DOI":"10.1016\/j.jalz.2015.08.003","volume":"12","author":"FH Duits","year":"2016","unstructured":"Duits FH, Martinez-Lage P, Paquet C, Engelborghs S, Lle\u00f3 A, Hausner L, et al. Performance and complications of lumbar puncture in memory clinics: Results of the multicenter lumbar puncture feasibility study. Alzheimers Dement. 2016;12:154\u201363.","journal-title":"Alzheimers Dement"},{"key":"1955_CR11","doi-asserted-by":"publisher","first-page":"275","DOI":"10.1001\/jama.2010.2008","volume":"305","author":"CM Clark","year":"2011","unstructured":"Clark CM, Schneider JA, Bedell BJ, Beach TG, Bilker WB, Mintun MA, et al. Use of florbetapir-PET for imaging beta-amyloid pathology. JAMA. 2011;305:275\u201383.","journal-title":"JAMA"},{"key":"1955_CR12","doi-asserted-by":"publisher","first-page":"669","DOI":"10.1016\/S1474-4422(12)70142-4","volume":"11","author":"CM Clark","year":"2012","unstructured":"Clark CM, Pontecorvo MJ, Beach TG, Bedell BJ, Coleman RE, Doraiswamy PM, et al. Cerebral PET with florbetapir compared with neuropathology at autopsy for detection of neuritic amyloid-\u03b2 plaques: a prospective cohort study. Lancet Neurol. 2012;11:669\u201378.","journal-title":"Lancet Neurol"},{"key":"1955_CR13","doi-asserted-by":"publisher","first-page":"287","DOI":"10.1001\/jamaneurol.2014.4144","volume":"72","author":"C Curtis","year":"2015","unstructured":"Curtis C, Gamez JE, Singh U, Sadowsky CH, Villena T, Sabbagh MN, et al. Phase 3 trial of flutemetamol labeled with radioactive fluorine 18 imaging and neuritic plaque density. JAMA Neurol. 2015;72:287\u201394.","journal-title":"JAMA Neurol"},{"key":"1955_CR14","doi-asserted-by":"publisher","first-page":"1370","DOI":"10.1093\/brain\/awv050","volume":"138","author":"ME Murray","year":"2015","unstructured":"Murray ME, Lowe VJ, Graff-Radford NR, Liesinger AM, Cannon A, Przybelski SA, et al. Clinicopathologic and 11C-Pittsburgh compound B implications of Thal amyloid phase across the Alzheimer\u2019s disease spectrum. Brain. 2015;138:1370\u201381.","journal-title":"Brain"},{"key":"1955_CR15","doi-asserted-by":"publisher","first-page":"241","DOI":"10.1053\/j.semnuclmed.2020.12.005","volume":"51","author":"N Krishnadas","year":"2021","unstructured":"Krishnadas N, Villemagne VL, Dor\u00e9 V, Rowe CC. Advances in Brain Amyloid Imaging. Semin Nucl Med. 2021;51:241\u201352.","journal-title":"Semin Nucl Med"},{"key":"1955_CR16","doi-asserted-by":"publisher","first-page":"271","DOI":"10.1007\/s12149-023-01824-1","volume":"37","author":"YJ Jeong","year":"2023","unstructured":"Jeong YJ, Yoon HJ, Kang D-Y, Park KW. Quantitative comparative analysis of amyloid PET images using three radiopharmaceuticals. Ann Nucl Med. 2023;37:271\u20139.","journal-title":"Ann Nucl Med"},{"key":"1955_CR17","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.jalz.2014.07.003","volume":"11","author":"WE Klunk","year":"2015","unstructured":"Klunk WE, Koeppe RA, Price JC, Benzinger TL, Devous MD, Jagust WJ, et al. The Centiloid Project: standardizing quantitative amyloid plaque estimation by PET. Alzheimers Dement. 2015;11:1-15.e1-4.","journal-title":"Alzheimers Dement"},{"key":"1955_CR18","doi-asserted-by":"publisher","first-page":"3508","DOI":"10.1007\/s00259-022-05784-y","volume":"49","author":"HG Pemberton","year":"2022","unstructured":"Pemberton HG, Collij LE, Heeman F, Bollack A, Shekari M, Salvad\u00f3 G, et al. Quantification of amyloid PET for future clinical use: a state-of-the-art review. Eur J Nucl Med Mol Imaging. 2022;49:3508\u201328.","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"1955_CR19","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1002\/brb3.2499","volume":"12","author":"H Matsuda","year":"2022","unstructured":"Matsuda H, Yamao T. Software development for quantitative analysis of brain amyloid PET. Brain Behav. 2022;12:1\u201310.","journal-title":"Brain Behav"},{"key":"1955_CR20","doi-asserted-by":"publisher","first-page":"213","DOI":"10.1037\/h0026256","volume":"70","author":"J Cohen","year":"1968","unstructured":"Cohen J. Weighted kappa: nominal scale agreement provision for scaled disagreement or partial credit. Psychol Bull. 1968;70:213\u201320.","journal-title":"Psychol Bull"},{"key":"1955_CR21","doi-asserted-by":"publisher","first-page":"50","DOI":"10.1038\/nature19323","volume":"537","author":"J Sevigny","year":"2016","unstructured":"Sevigny J, Chiao P, Bussi\u00e8re T, Weinreb PH, Williams L, Maier M, et al. The antibody aducanumab reduces A\u03b2 plaques in Alzheimer\u2019s disease. Nature. 2016;537:50\u20136.","journal-title":"Nature"},{"key":"1955_CR22","doi-asserted-by":"publisher","first-page":"863","DOI":"10.1007\/s40120-023-00473-w","volume":"12","author":"AA Tahami Monfared","year":"2023","unstructured":"Tahami Monfared AA, Ye W, Sardesai A, Folse H, Chavan A, Aruffo E, et al. A path to improved Alzheimer\u2019s care: simulating long-term health outcomes of lecanemab in early Alzheimer\u2019s disease from the CLARITY AD trial. Neurol Ther. 2023;12:863\u201381.","journal-title":"Neurol Ther"},{"key":"1955_CR23","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1056\/NEJMoa2212948","volume":"388","author":"CH van Dyck","year":"2023","unstructured":"van Dyck CH, Swanson CJ, Aisen P, Bateman RJ, Chen C, Gee M, et al. Lecanemab in early Alzheimer\u2019s disease. N Engl J Med. 2023;388:9\u201321.","journal-title":"N Engl J Med"},{"key":"1955_CR24","doi-asserted-by":"publisher","first-page":"5","DOI":"10.1007\/s40259-023-00633-2","volume":"38","author":"J Cummings","year":"2024","unstructured":"Cummings J, Osse AML, Cammann D, Powell J, Chen J. Anti-amyloid monoclonal antibodies for the treatment of Alzheimer\u2019s disease. BioDrugs. 2024;38:5\u201322.","journal-title":"BioDrugs"},{"key":"1955_CR25","volume":"8","author":"J Cummings","year":"2022","unstructured":"Cummings J, Lee G, Nahed P, Kambar MEZN, Zhong K, Fonseca J, et al. Alzheimer\u2019s disease drug development pipeline: 2022. Alzheimer\u2019s Dement (New York, N Y). 2022;8: e12295.","journal-title":"Alzheimer\u2019s Dement (New York, N Y)"},{"key":"1955_CR26","doi-asserted-by":"publisher","first-page":"406","DOI":"10.1016\/j.nicl.2018.04.022","volume":"19","author":"Y Su","year":"2018","unstructured":"Su Y, Flores S, Hornbeck RC, Speidel B, Vlassenko AG, Gordon BA, et al. Utilizing the Centiloid scale in cross-sectional and longitudinal PiB PET studies. NeuroImage Clin. 2018;19:406\u201316.","journal-title":"NeuroImage Clin"},{"key":"1955_CR27","doi-asserted-by":"publisher","first-page":"3276","DOI":"10.1007\/s00259-023-06279-0","volume":"50","author":"A Jovalekic","year":"2023","unstructured":"Jovalekic A, Ro\u00e9-Vellv\u00e9 N, Koglin N, Quintana ML, Nelson A, Diemling M, et al. Validation of quantitative assessment of florbetaben PET scans as an adjunct to the visual assessment across 15 software methods. Eur J Nucl Med Mol Imaging. 2023;50:3276\u201389.","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"1955_CR28","doi-asserted-by":"publisher","first-page":"346","DOI":"10.1016\/j.neuroimage.2016.12.010","volume":"147","author":"CN Ladefoged","year":"2017","unstructured":"Ladefoged CN, Law I, Anazodo U, St Lawrence K, Izquierdo-Garcia D, Catana C, et al. A multi-centre evaluation of eleven clinically feasible brain PET\/MRI attenuation correction techniques using a large cohort of patients. Neuroimage. 2017;147:346\u201359. https:\/\/doi.org\/10.1016\/j.neuroimage.2016.12.010","journal-title":"Neuroimage."},{"key":"1955_CR29","doi-asserted-by":"publisher","first-page":"106669","DOI":"10.1016\/j.clineuro.2021.106669","volume":"206","author":"G Sager","year":"2021","unstructured":"Sager G, Akgun E, Abuqbeitah M, Uslu L, Asa S, Akgun MY, et al. Comparison of brain F-18 FDG PET\/MRI with PET\/CT imaging in pediatric patients. Clin Neurol Neurosurg [Internet]. 2021;206:106669. https:\/\/doi.org\/10.1016\/j.clineuro.2021.106669.","journal-title":"Clin Neurol Neurosurg [Internet]"},{"key":"1955_CR30","doi-asserted-by":"publisher","first-page":"1500","DOI":"10.1007\/s00247-017-3888-8","volume":"47","author":"MJ Paldino","year":"2017","unstructured":"Paldino MJ, Yang E, Jones JY, Mahmood N, Sher A, Zhang W, et al. Comparison of the diagnostic accuracy of PET\/MRI to PET\/CT-acquired FDG brain exams for seizure focus detection: a prospective study. Pediatr Radiol. 2017;47:1500\u20137.","journal-title":"Pediatr Radiol"}],"container-title":["Annals of Nuclear Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12149-024-01955-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s12149-024-01955-z\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12149-024-01955-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,9,14]],"date-time":"2024-09-14T08:18:04Z","timestamp":1726301884000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s12149-024-01955-z"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,6,20]]},"references-count":30,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2024,10]]}},"alternative-id":["1955"],"URL":"https:\/\/doi.org\/10.1007\/s12149-024-01955-z","relation":{},"ISSN":["0914-7187","1864-6433"],"issn-type":[{"value":"0914-7187","type":"print"},{"value":"1864-6433","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,6,20]]},"assertion":[{"value":"15 February 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"11 June 2024","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"20 June 2024","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors have no relevant financial or nonfinancial interests to disclose.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"The study was approved by the Research Ethics Committee of Fukushima Medical University (no. REC2023-137). This study was conducted in accordance with the ethical standards of the 1964 Declaration of Helsinki and its subsequent amendments.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval"}},{"value":"This cross-sectional retrospective study was approved by our institutional ethics committee. The requirement for written informed consent was waived due to data anonymization and the retrospective nature of the study.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent"}}]}}